Funding
← Back to your selection

Qatar Investment Authority (QIA)

Activity from announced rounds

Activity in this selectionMar 31, 2025 · Mar 1, 2025
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$150M
1 disclosed · full round size, not this investor’s share

By stage

Series B1

By primary sector

Biotech1

By country

United States1

Rounds

1 in this selection
Latigo Biotherapeutics

Latigo Biotherapeutics develops non-opioid pain medicines that target peripheral pain signaling.

$150MSeries B
Participant